Retrospective Study
Copyright ©The Author(s) 2022.
World J Orthop. Apr 18, 2022; 13(4): 381-387
Published online Apr 18, 2022. doi: 10.5312/wjo.v13.i4.381
Table 1 Patient’s demographics
Patient
Sex
Age in yr
Underlying condition
Site
Position
Size in cm
Procedure time in min
Presenting complaint
Catheter withdrawal in d
Microbiologic cultures
1Male76Renal failure- dialysisUnilateralProne4.515Back pain8Negative
2Female69Renal failure- dialysisUnilateralProne6.415Back pain, weight loss10Negative
3Male74Renal failure- dialysisBilateralProne7.5/4.525Back pain8Staphylococcus aureus
4Female68Renal failure- dialysisUnilateralProne4.410Back pain9Staphylococcus aureus
5Female34HIVBilateralProne5.5/4.325Back pain8Staphylococcus aureus
6Male35IV drug userUnilateralSupine8.310Back pain13Negative
7Male38TuberculosisUnilateralProne7.515Back pain11Mycobacterium tuberculosis
8Female27TuberculosisUnilateralProne10.415Back pain14Mycobacterium tuberculosis
Table 2 Culture results and antibiotic treatment
Microorganism
n
Antibiotic treatment
Duration
Staphylococcus aureus 3Rifampicin PO - Vancomycin IV2 wk
Rifampicin PO - Linezolid PO6 wk
Mycobacterium tuberculosis2Rifampicin PO - Isoniazid PO - Ethambutol PO9 mo
Negative cultures, renal impairment patients2Vancomycin IV - Ciprofloxacin PO8 wk
Negative cultures, IV drug user1Ciprofloxacin PO - Clindamycin PO4 wk
Ciprofloxacin PO - Rifampicin PO3 wk